Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
DynaMedex merges the clinical acumen and meticulously curated disease information from DynaMed with the thorough overview of treatment options, expansive drug data, and AI-driven search functionalities of Micromedex. It equips users with evidence-based insights that facilitate superior clinical decision-making and enhance patient outcomes. Clinicians utilizing DynaMedex can effortlessly search, browse, and stay updated on the topics and specialties that are most relevant to their practice, receiving both quick responses and comprehensive insights into their drug inquiries. Delve into this innovative tool and discover how it fosters improved clinical decision-making. Users can swiftly obtain answers to their drug-related questions through intuitive and conversational search features. The "Ask Watson" assistant employs artificial intelligence to streamline access to drug information, eliminating the need for traditional keyword searches in favor of natural language queries, allowing users to communicate in their own words and receive the information they seek efficiently. This seamless integration of AI technology not only saves time but also empowers healthcare professionals to make informed decisions with greater ease.
Description
Rare diseases often lack comprehensive research, resulting in insufficient knowledge about essential elements for an effective drug discovery initiative. Our innovative AI platform, Healnet, addresses these issues by scrutinizing vast amounts of drug and disease data to uncover new connections that may lead to potential treatments. Utilizing cutting-edge technologies throughout the discovery and development process allows us to operate multiple phases simultaneously and on a large scale. The conventional approach of focusing on a single disease, target, and drug is overly simplistic, yet it remains the standard for most pharmaceutical companies. The future of drug discovery is driven by AI, characterized by parallel processes and an absence of rigid hypotheses, fundamentally integrating the three core paradigms of drug discovery into a cohesive strategy. This new paradigm not only enhances efficiency but also fosters creativity in developing solutions for complex health challenges.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
Free
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
EBSCO
Country
United States
Website
www.ebsco.com/clinical-decisions/dynamed-solutions/dynamedex
Vendor Details
Company Name
Healx
Founded
2014
Country
United Kingdom
Website
healx.io/technology/